CEFIXIME — all Canadian products
9 DINs
5 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is CEFIXIME, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02432773 | AURO-CEFIXIME | AURO PHARMA INC | Tablet | Oral | CEFIXIME 400 MG | Marketed | |
| 02468689 | AURO-CEFIXIME | AURO PHARMA INC | Powder For Suspension | Oral | CEFIXIME 100 MG | Marketed | |
| 02572621 | JAMP CEFIXIME | JAMP PHARMA CORPORATION | Powder For Suspension | Oral | CEFIXIME 100 MG | Approved | |
| 00868965 | SUPRAX | ODAN LABORATORIESLTD | Powder For Suspension | Oral | CEFIXIME 100 MG | Marketed | |
| 00868981 | SUPRAX | ODAN LABORATORIESLTD | Tablet | Oral | CEFIXIME 400 MG | Marketed | |
| 00868973 | SUPRAX | SANOFI-AVENTIS CANADA INC | Tablet | Oral | CEFIXIME 200 MG | Cancelled Post Market | |
| 02195984 | SUPRAX | AVENTIS PHARMA INC | Tablet | Oral | CEFIXIME 400 MG | Cancelled Post Market | |
| 02195992 | SUPRAX | AVENTIS PHARMA INC | Powder For Solution | Oral | CEFIXIME 100 MG | Cancelled Post Market | |
| 02195976 | SUPRAX - TAB 200MG | RHONE-POULENC RORER CANADA INC. | Tablet | Oral | CEFIXIME 200 MG | Cancelled Post Market |
Browse other molecules: